Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    ST6GAL1
Show Display Options
Rank Status Study
1 Completed A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints
Conditions: Memory Disorders, Age-Related;   Retention Disorders, Cognitive
Interventions: Drug: EGb 761®  (Tanakan®);   Other: Placebo
2 Recruiting Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Condition: Idiopathic Venous Thromboembolism
Intervention: Other: Application of the"Men continue and HER DOO2" rule
3 Terminated Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.
Condition: Atrial Fibrillation
Intervention: Drug: Flecainide
4 Recruiting Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Condition: HER2 Low to Intermediate Breast Cancer
Interventions: Biological: NeuVax™ vaccine;   Biological: Leukine® (sargramostim, GM-CSF) and water for injection
5 Recruiting The Designer D-dimer Deep Vein Thrombosis Diagnosis (4D) Study
Condition: Suspected Deep Vein Thrombosis
Intervention:
6 Recruiting A Study to Evaluate the Safety of Withholding Anticoagulation in Patients With Subsegmental PE Who Have a Negative Serial Bilateral Lower Extremity Ultrasound
Condition: Subsegmental (Single or Multiple) Pulmonary Embolism
Intervention:

Indicates status has not been verified in more than two years